Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $67.5900 (-0.68%) ($67.5900 - $68.6300) on Wed. Jul. 19, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.13% (three month average) | RSI | 25 | Latest Price | $67.5900(-0.68%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.4% a day on average for past five trading days. | Weekly Trend | LGND declines -2.8% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) XBI(45%) IBB(42%) XHB(38%) UNG(36%) XAR(36%) | Factors Impacting LGND price | LGND will decline at least -1.065% in a week (0% probabilities). TBT(-22%) UUP(-21%) VXX(-18%) XLU(-11%) VIXM(-6%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.065% (StdDev 2.13%) | Hourly BBV | -1.7 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $62.3(-7.83%) | Resistance Level | $70.77 | 5 Day Moving Average | $68.12(-0.78%) | 10 Day Moving Average | $68.78(-1.73%) | 20 Day Moving Average | $70.77(-4.49%) | To recent high | -15.1% | To recent low | 0% | Market Cap | $1.086b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |